BIOREGULATOR / DIRECT CATALOG PRICING
Pinealon
Pinealon is identified in primary literature as the tripeptide Glu-Asp-Arg (EDR). It is a Russian bioregulator trade name and does not independently authenticate catalog material.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Bioregulator
Choose a listed format
- 20 mgRequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Pinealon is identified in primary literature as the tripeptide Glu-Asp-Arg (EDR). It is a Russian bioregulator trade name and does not independently authenticate catalog material.
The bioregulator classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Bioregulator
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Pinealon is identified in primary literature as the tripeptide Glu-Asp-Arg (EDR). It is a Russian bioregulator trade name and does not independently authenticate catalog material.
- Research covered
- EDR was studied in offspring of rats exposed to prenatal hyperhomocysteinemia, with behavioral and neuronal oxidative-stress endpoints. Fluorescently labeled EDR was also studied in HeLa cells for cellular and nuclear penetration and oligonucleotide interactions. A small human study administered Pinealon together with Vesugen, preventing attribution to either peptide alone.
- Important limit
- Most evidence is animal or cell-based, and the small human report is combined, uncontrolled, and not independently confirmatory. No general cognitive effect is established; vial identity and purity require testing.
FACTUAL FAQ
Pinealon catalog questions
What formats are currently listed?
20 mg. Current price and stock state appear above.
What did researchers study?
EDR was studied in offspring of rats exposed to prenatal hyperhomocysteinemia, with behavioral and neuronal oxidative-stress endpoints. Fluorescently labeled EDR was also studied in HeLa cells for cellular and nuclear penetration and oligonucleotide interactions. A small human study administered Pinealon together with Vesugen, preventing attribution to either peptide alone.
What is the most important evidence limit?
Most evidence is animal or cell-based, and the small human report is combined, uncontrolled, and not independently confirmatory. No general cognitive effect is established; vial identity and purity require testing.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →